Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Supply of pembrolizumab under drug programme B.6, Institute of Tuberculosis and Lung Diseases

Open · 27 days left Poland · Medicines

BuyerInstytut Gruzlicy i Chorob Pluc (National Institute of Tuberculosis and Lung Diseases), Warsaw
ReferenceAP.26.101.2026
Closing date15 December 2026
ProductsPembrolizumab reimbursed under the National Health Fund drug programme B.6 (lung cancer). Open tender published 12 Nov 2026.

Read the official notice

PharmaTradz is not the buyer. Read the full tender documents and any addenda on the buyer's site before bidding; they always prevail over this summary.

Typical documents for a medicines tender

  • Registration in the buyer's country, or the alternative the tender accepts (for example WHO prequalification)
  • GMP certificate for the manufacturing site and a certificate of pharmaceutical product (CoPP)
  • Certificates of analysis, samples, stability data and labelling in the required language
  • Bid security, authorisation letters and price schedules in the buyer's format

Need a supplier for this tender?

Tell us the lots, strengths and quantities. We match registered, GMP-certified manufacturers and can help with tender documents.

Request supplier quotes

New tenders in Poland

We email you when new tenders for this country are listed. Confirm first; unsubscribe any time.

Other open tenders

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us